filed
on 15 Apr 2024
Last Applicant/ Owned by
One Amgen Center Drive
Thousand Oaks
CA
91320-179
Serial Number
97353493 filed on 08th Apr 2022
Registration Number
N/A
Correspondent Address
ELSA D. LEMOINE
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmRead More
pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure
No 97353493
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
16th Apr 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
15th Apr 2024 | SOU TEAS EXTENSION RECEIVED |
15th Apr 2024 | SOU EXTENSION 1 FILED |
15th Apr 2024 | SOU EXTENSION 1 GRANTED |
12th Dec 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
01st Nov 2023 | OPPOSITION DISMISSED NO. 999999 |
01st Nov 2023 | OPPOSITION TERMINATED NO. 999999 |
01st Nov 2023 | TTAB RELEASE CASE TO TRADEMARKS |
28th Sep 2023 | OPPOSITION INSTITUTED NO. 999999 |
27th Apr 2023 | EXTENSION OF TIME TO OPPOSE RECEIVED |